Oncotarget has become popular recently due to its punctual, insightful, and constructive peer review. This is something that has helped authors improve and increase their research impact. The members of the editorial board have published over ten papers and twenty-seven reviews in Oncotarget. In fact, in 2013, four members of Oncotarget won the highest possible prize, the Breakthrough Prize. The term Oncotarget refers to all molecules, cellular functions, and pathways that are common in aging and cancer, atherosclerosis, neurodegeneration, cancer cells, lymphocytes, and neurons as well as microbes.
Oncotarget is a free access, traditional multidisciplinary journal. It has a routine of publishing papers on weekly issues. However, in the event of special demand content, the papers can be printed immediately. The mission of Oncotarget is to make it possible for people to access scientific research results and findings easily. In addition, it aims at maximizing the impact of research through insightful review. Oncotarget allows exceptional discoveries in the science world to be shared quickly. It also strives to eliminate border specialties and provide a linkage to different medical fields in the biomedical science. Oncotarget also tries to foster applications for basic and clinical science as a way of fighting diseases. The journal is peer reviewed and is published by Impact Journals.
It is under the leadership of some of the most prominent scientists around the globe who make it possible for the journal to help researchers make adequate contributions to the progress of science life. In fact, the main aim of Oncotarget is to achieve a life that is free of diseases. With the success of the journal, the leadership has been prompted to expand the publications to go beyond sections on oncology.
Some of the other areas include aging, pathology beyond oncology, metabolism, endocrinology, cell biology, autophagy and cell death, cardiology, immunology, and microbiology as well as chromosomes. With continued research and publishing of findings from the best scientists around the world, the fight against diseases gets to move ahead by one more step. In fact, oncology is encouraging scientists and accepting papers in all sectors of scientific research. Anything that will contribute towards offering better health care is welcomed. Oncotarget is also available on Dove Press.